Should all women with PCOS be treated for insulin resistance?

Fertility and Sterility

Volumn 97, Issue 1, 2012, Pages 18-22

  Marshall, John C ^a   Dunaif, Andrea ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANDROGEN; CLOMIFENE; GONADORELIN; GONADOTROPIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN SENSITIZING AGENT; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ANDROGEN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET; DRUG EFFICACY; EXERCISE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HEART MUSCLE REVASCULARIZATION; HIRSUTISM; HORMONE RELEASE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEG AMPUTATION; LIFESTYLE MODIFICATION; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 84055172782     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.11.036     Document Type: Article

References (71)

1. J. Zawadzki, and A. Dunaif Diagnostic criteria for polycystic ovary syndrome: towards a rational approach A. Dunaif, J. Givens, F. Haseltine, G. Merriam, Polycystic ovary syndrome 1992 Blackwell Scientific Oxford, UK 377 384
2. R. Azziz, E. Carmina, E. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, and W. Futterweit Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline J Clin Endocrinol Metab 91 2006 4237 4245 (Pubitemid 44833391)
3. C.M. DeUgarte, A.A. Barolucci, and R. Azziz Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment Fertil Steril 83 2005 1454 1460 (Pubitemid 40615820)
4. R. Mathur, C.J. Alexander, J. Yano, B. Trivax, and R. Azziz Use of metformin in polycystic ovary syndrome Am J Obstet Gynecol 199 2008 596 609
5. T.P. Ciaraldi, A. el-Roeiy, Z. Madar, D. Reichart, J.M. Olefsky, and S.S. Yen Cellular mechanisms of insulin resistance in polycystic ovarian syndrome J Clin Endocrinol Metab 75 1992 577 583
6. A. Dunaif, J. Xia, C.B. Book, E. Schenker, and Z. Tang Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome J Clin Invest 96 1995 801 810
7. J.E. Nestler, D.J. Jakubowicz, A.F. deVargas, C. Brik, N. Quintero, and F. Medina Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositoglycan mediators as the signal transduction system J Clin Endocrinol Metab 83 1998 2001 2005 (Pubitemid 28496328)
8. S. Franks, C. Gilling-Smith, H. Watson, and D. Willis Insulin action in the normal and polycystic ovary Endocrinol Metab Clin North Am 28 1999 361 378 (Pubitemid 29242718)
9. S.K. Blank, C.R. McCartney, S. Chhabra, K.D. Helm, C.A. Eagleson, and R.J. Chang Modulation of GnRH pulse generator sensitivity to progesterone inhibition in hyperandrogenemic adolescent girls: implications for regulation of pubertal maturation J Clin Endocrinol Metab 94 2009 2360 2366
10. S.L. Berga Polycystic ovary syndrome: a model of combinational endocrinology J Clin Endocrinol Metab 94 2009 2250 2251
11. S.B. Kristiansen, A. Endoh, P.R. Casson, J.E. Buster, and P.J. Hornsby Induction of steroidogenic enzyme genes by insulin and IGF-1 in cultured adult human adrenocortical cells Steroids 62 1997 258 265 (Pubitemid 27114621)
12. P. Moghetti, R. Castello, C. Negri, F. Tosi, G.G. Spiazzi, and E. Brun Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17, 20-lyase activity J Clin Endocrinol Metab 81 1996 881 886 (Pubitemid 26083940)
13. P.A. Essah, E.P. Wickham, and J.E. Nestler The metabolic syndrome in polycystic ovary syndrome Clin Obstet Gynecol 50 2007 205 225 (Pubitemid 46279863)
14. D.A. Ehrmann, D.R. Lijenquist, K. Kasza, R. Azziz, R.S. Legro, and M.N. Ghazzi Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome J Clin Endocrinol Metab 91 2006 48 53 (Pubitemid 43069116)
15. R.J. Norman, M.J. Davies, J. Lord, and L.J. Moran The life style modification in polycystic ovary syndrome Trends Endocrinol Metab 13 2002 251 257 (Pubitemid 36733970)
16. K.M. Hoeger Exercise therapy in polycystic ovary syndrome Semin Reprod Med 26 2008 93 100
17. D. Ehrmann, D.J. Schneider, and B.E. Sobel Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis and fibrinolysis in women with polycystic ovary syndrome J Clin Endocrinol Metab 82 1997 2108 2116 (Pubitemid 27287569)
18. A. Dunaif, D. Scott, D. Finegood, B. Quintana, and R. Whitcomb The insulin sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome J Clin Endocrinol Metab 81 1996 3299 3306 (Pubitemid 26296206)
19. G. Zhou, R. Myers, Y. Li, Y. Chen, and X. Shen Role of AMP activated protein kinase in mechanism of metformin action J Clin Invest 108 2001 1167 1174 (Pubitemid 32995375)
20. C. Bailey, and R. Turner Metformin N Engl J Med 334 1996 574 579 (Pubitemid 126537875)
21. J.M. Lord, I.H.K. Flight, and R.J. Norman Metformin in polycystic ovary syndrome: systematic review and meta-analysis Brit Med J 327 2003 951 956
22. A.A. Creanga, H.M. Bradley, C. McCormick, and C.T. Witkop Use of metformin in polycystic ovary syndrome: a meta-analysis Ob Gyn 111 2008 959 968 (Pubitemid 351482630)
23. S.R. Salpeter, N.S. Buckley, J.A. Kahn, and E.E. Salpeter Meta-analysis: metformin treatment in persons at risk for diabetes mellitus Am J of Med 121 2008 149 157
24. J.P. Ballargeon, D.J. Jakubowicz, M.J. Iuomo, S. Jakubowicz, and J.E. Nestler Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity Fertil Steril 82 2004 893 902 (Pubitemid 39346435)
25. C. Ortega-Gonzalez, S. Luna, L. Hernandez, G. Crespo, P. Aguayo, and G. Arteaga-Troncoso Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin resistant women with polycystic ovary syndrome J Clin Endocrinol Metab 90 2005 1360 1365 (Pubitemid 40463988)
26. M. Costello, B. Shrestha, J. Eden, P. Sjoblom, and N. Johnson Insulin-sensitizing drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome Cochrane Database Syst Rev 1 2007 CD005552
27. C.R. McCartney, K.A. Prendergast, S. Chhabra, C.A. Eagleson, R. Yoo, and R.J. Chang The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyerandrogenism J Clin Endocrinol Metab 91 2006 1714 1722
28. C.R. McCartney, S.K. Blank, K.A. Prendergast, S. Chhabra, C.A. Eagleson, and K.D. Helm Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls J Clin Endocrinol Metab 92 2007 430 436
29. K.L. Knudsen, S.K. Blank, C. Burt-Solorzano, J.S. Patne, R.J. Chang, and S. Caprio Hyperandrogenemia in obese peripubertal girls: Correlates and potential etiological determinants Obesity 18 2010 2118 2124
30. R.L. Rosenfield Identifying children at risk for polycystic ovary syndrome J Clin Endocrinol Metab 92 2007 787 796 (Pubitemid 46465641)
31. D. Apter, T. Bützow, G.A. Laughlin, and S.S. Yen Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome J Clin Endocrinol Metab 79 1994 119 125 (Pubitemid 24221170)
32. S.K. Blank, C.R. McCartney, and J.C. Marshal The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome HumReprod Update 12 2006 351 361 (Pubitemid 43923410)
33. C.A. Eagleson, M.B. Gingrich, C.L. Pastor, T.K. Arora, C.M. Burt, and W.S. Evans Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the GnRH pulse generator to inhibition by estradiol and progesterone J Clin Endocrinol Metab 85 2000 4047 4052 (Pubitemid 32055351)
34. S.A. Arslanian, V. Lewy, K. Danadian, and R. Saad Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance J Clin Endocrinol Metab 87 2002 1555 1559 (Pubitemid 34615238)
35. C.J. Glueck, J.A. Morrison, S. Daniels, P. Wang, and D. Stroop Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years J Pediatrics 159 2011 308 313
36. A. Dunaif Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocr Rev 18 1997 774 800 (Pubitemid 28009567)
37. L. Moran, and H. Teede Metabolic features of the reproductive phenotypes of polycystic ovary syndrome Hum Reprod Update 15 2009 477 488
38. A. Dunaif, K.R. Segal, W. Futterweit, and A. Dobrjansky Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165 1174 (Pubitemid 19250404)
39. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E214 E223
40. P. Ovesen, J. Moller, H.J. Ingerslev, J.O. Jorgensen, A. Mengel, and O. Schmitz Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome J Clin Endocrinol Metab 77 1993 1636 1640 (Pubitemid 24000926)
41. A. Dunaif, M. Graf, J. Mandeli, V. Laumas, and A. Dobrjansky Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia J Clin Endocrinol Metab 65 1987 499 507 (Pubitemid 17131438)
42. S. Robinson, D. Kiddy, S.V. Gelding, D. Willis, R. Niththyananthan, and A. Bush The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries Clin Endocrinol (Oxf) 39 1993 351 355 (Pubitemid 23274435)
43. T.M. Barber, J.A.H. Wass, M.I. McCarthy, and S. Franks Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome Clin Endocrinol (Oxf) 66 2007 513 517 (Pubitemid 46434931)
44. V.P. Jovanovic, E. Carmina, and R.A. Lobo Not all women diagnosed with PCOS share the same cardiovascular risk profiles Fertil Steril 94 2010 826 832
45. E.B. Johnstone, M.P. Rosen, R. Neril, D. Trevithick, B. Sternfeld, and R. Murphy The polycystic ovary post-Rotterdam: A common, age-dependent finding in ovulatory women without metabolic significance J Clin Endocrinol Metab 95 2010 4965 4972
46. A. Dunaif Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome-a reappraisal Nat Clin Pract Endocrinol Metab 4 2008 272 283 (Pubitemid 351571139)
47. T. Tang, J.M. Lord, R.J. Norman, E. Yasmin, and A.H. Balen Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Cochrane Database Syst Rev 20 2010 CD003053
48. R.S. Legro, H.X. Barnhart, W.D. Schlaff, B.R. Carr, M.P. Diamond, and S.A. Carson Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome N Engl J Med 356 2007 551 566 (Pubitemid 46220816)
49. European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine Consensus on infertility treatment related to polycystic ovary syndrome Fertil Steril 89 2008 505 522
50. E. Vanky, S. Stridsklev, R. Heimstad, P. Romundstad, K. Skogoy, and O. Kleggetveit Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study J Clin Endocrinol Metab 95 2010 E448 E455
51. K.A. Martin, R.J. Chang, D.A. Ehrmann, L. Ibanez, R.A. Lobo, and R.L. Rosenfield Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline J Clin Endocrinol Metab 93 2008 1105 1120 (Pubitemid 351519694)
52. J.P. Crandall, W.C. Knowler, S.E. Kahn, D. Marrero, J.C. Florez, and G.A. Bray The prevention of type 2 diabetes Nat Clin Pract Endocrinol Metab 4 2008 382 393 (Pubitemid 351881862)
53. T.J. Orchard, M. Temprosa, R. Goldberg, S. Haffner, R. Ratner, and S. Marcovina The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial Ann Intern Med 142 2005 611 619 (Pubitemid 40529957)
54. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, and E.A. Walker Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403 (Pubitemid 34437694)
55. Diabetes Prevention Program Research Group W.C. Knowler, S.E. Fowler, R.F. Hamman, C.A. Christophi, and H.J. Hoffman 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study Lancet 374 2009 1677 1686
56. J.P. Despres, B. Lamarche, P. Mauriege, B. Cantin, G.R. Dagenais, and S. Moorjani Hyperinsulinemia as an independent risk factor for ischemic heart disease N Engl J Med 334 1996 952 957 (Pubitemid 26114161)
57. J.A. Dormandy, B. Charbonnel, D.J. Eckland, E. Erdmann, M. Massi-Benedetti, and I.K. Moules Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289 (Pubitemid 41416583)
58. E. Ferrannini, and B. Balkau Insulin: in search of a syndrome Diabet Med 19 2002 724 729 (Pubitemid 35013849)
59. K. Hucking, R.M. Watanabe, D. Stefanovski, and R.N. Bergman OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself Obesity 16 2008 1938 1945
60. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
61. R.S. Legro, and A. Dunaif Fasting glucose to insulin ratio or product of glucose and insulin? J Clin Endocrinol Metab 84 1999 383 (Pubitemid 29036733)
62. J. Hrebicek, V. Janout, J. Malincikova, D. Horakova, and L. Cizek Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention J Clin Endocrinol Metab 87 2002 144 147 (Pubitemid 34084683)
63. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752 (Pubitemid 41532612)
64. D.M. Nathan, J.B. Buse, M.B. Davidson, E. Ferrannini, R.R. Holman, and R. Sherwin Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 2009 193 203
65. D.M. Nathan, M.B. Davidson, R.A. DeFronzo, R.J. Heine, R.R. Henry, and R. Pratley Impaired fasting glucose and impaired glucose tolerance: implications for care Diabetes Care 30 2007 753 759 (Pubitemid 46354366)
66. S. Singh, Y.K. Loke, and C.D. Furberg Long-term risk of cardiovascular events with rosiglitazone JAMA 298 2007 1189 1195 (Pubitemid 47403105)
67. A.M. Lincoff, K. Wolski, S.J. Nicholls, and S.E. Nissen Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus JAMA 298 2007 1180 1188 (Pubitemid 47403104)
68. J.D. Lewis, A. Ferrara, T. Peng, M. Hedderson, W.B. Bilker, and C.P. Quesenberry Risk of bladder cancer among diabetic patients treated with pioglitazone Diabetes Care 34 2011 916 922
69. Diabetes Prevention Program Research Group 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study Lancet 374 2009 1677 1686
70. K.A. Martin, R.J. Chang, D.A. Ehrmann, L. Ibanez, R.A. Lobo, and R.L. Rosenfield Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 93 2008 1105 1120 (Pubitemid 351519694)
71. E. Diamanti-Kandarakis, C. Kouli, K. Alexandraki, and G. Spina Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome J Clin Endocrinol Metab 89 2004 1273 1276 (Pubitemid 38368425)